To obtain credit, study the material and complete the CME Posttest and Registration Form as instructed at the end of each activity.
After completing each of these educational activities, you should be able to achieve the objective given in the activity.
Bipolar disorder, including mixed states, is associated with a high level of functional impairment. Effective management strategies that emphasize treatment of all phases of the illness may help reduce this impairment. One reason for poor long-term outcome in bipolar disorder is the misdiagnosis that often occurs because physicians lack knowledge about the presentation of bipolar disorder. Another reason is clinicians’ lack of knowledge about managing impulsivity and aggression, which are clinical markers for suicidal behavior in adolescents and often lead adults to urgent treatment. Finally, clinicians may not know enough about medications that are well-tolerated during the maintenance phase of illness. This activity was designed to meet the needs of participants in CME activities provided by the CME Institute of Physicians Postgraduate Press, Inc., who have requested information on bipolar disorder. There are no prerequisites for participating in this activity.
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The CME Institute of Physicians Postgraduate Press, Inc., designates each of these educational activities for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
In the spirit of full disclosure and in compliance with all ACCME Essential Areas and Policies, the faculty for this CME activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest (i.e., any proprietary entity producing health care goods or services consumed by, or used on, patients) occurring within the 12 months prior to joining this activity. The CME Institute has resolved any conflicts of interest that were identified. The disclosures are as follows:
Dr. Jain is a consultant for Cyberonics, Addrenex, Eli Lilly, Impax, and Takeda; has received grant/research support from Abbott, GlaxoSmithKline, Eli Lilly, and Merck; and is a member of the speakers/advisory boards for Cyberonics, GlaxoSmithKline, Eli Lilly, and Roche. [article list]
Dr. Manning is a consultant for and is a member of the speakers/advisory boards for Eli Lilly and AstraZeneca. [article list]
Dr. Garlow is a consultant for Eli Lilly and Solvay; has received grant/research support from Janssen; has received honoraria from Postgraduate Institute of Medicine; and is a member of the speakers/advisory boards for Eli Lilly and Pfizer. [article list]
Dr. Skale is a consultant for, has received honoraria from, and is a member of the speakers/advisory boards for Eli Lilly. [article list]
Dr. Jackson is a consultant for Eli Lilly and has received honoraria from and is a member of the speakers/advisory boards for Eli Lilly and AstraZeneca. [article list]
Dr. Gardner is a consultant for Eli Lilly and is a member of the speakers/advisory boards for Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest, GlaxoSmithKline, Pfizer, and Roche. [article list]
Dr. Maletic is a consultant for Eli Lilly and Cephalon and has received honoraria from and is a member of the speakers/advisory boards for Eli Lilly, Cephalon, and Novartis. [article list]
In these Brief Reports, investigational information about pharmaceutical agents may be presented that is outside U.S. Food and Drug Administration-approved labeling. This information is intended solely as continuing medical education and is not intended to promote off-label use of any of these medications. Please consult the paragraph title “Disclosure of Off-Label Usage” at the end of each Brief Report for a complete listing of off-label or investigational uses. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
This activity has undergone a 3-tier review process: (1) the entire faculty of the series discussed the content at a peer-review planning session; (2) the Chair reviewed the activity for accuracy and fair balance; and (3) a member of the External CME Advisory Board reviewed the activity to determine whether the material is evidence-based and objective.
These Brief Reports are developed from the planning teleconference series "Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy," which was held in March and April 2007 and was independently developed by the CME Institute of Physicians Postgraduate Press, Inc., pursuant to an educational grant from Eli Lilly and Company. The opinions expressed herein are those of the faculty and do not necessarily reflect the opinions of the CME provider and publisher or the commercial supporter.
 |
|
| Chair Rakesh Jain, MD, MPH | |
| Project Assistants | Ariel A. Britton, MA Anna Esquivel, MA Julie L. Hoffman, MFA Aaron Worcester, BA |
| Project Associate | Sally A. Elliott, BA |
| Project Manager | Kathryn Maceri, BA |
| Electronic Media Manager | F. Grant Whittle, PhD |
| Managing Director | Jane B. Eckstein, MA |
| Associate CME Director | Jennifer G. Alessi, MA |
| Assistant CME Director | Susan K. Beaton, BS |
| CME Editor | Becky Brown Derych, MA |
| CME Coordinator | Diane Brunner |
| External CME Advisory Board | |
Chair Michael H. Ebert, MD Vice Chair Richard C. Shelton, MD |
|
E. Sherwood Brown, PhD, MD Stephanie Cavanaugh, MD Lawrence J. Cohen, PharmD Larry Culpepper, MD, MPH John M. Downs, MD Alan J. Gelenberg, MD |
Paul King, MD Joseph A. Lieberman, III, MD Elizabeth H. B. Lin, MD Frank W. Ling, MD J. Sloan Manning, MD Meir Steiner, MD, PhD |
© 2007 Physicians Postgraduate Press, Inc. |
|
Psychiatrist.com Home
Keyword Search